OpenBilldrug price receipt

NADAC week of 2026-10-14

TERIPARATIDE 560 MCG/2.24 ML PEN

For 2.24 mL

Pharmacies pay

$1,075.09 filed

2.24 × $479.95105 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$2,155.86 filed

2.24 × $962.4375 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.0× estimated

Medicare paid 2.0× what pharmacies pay.

Part D averages every strength and form sold under “Teriparatide” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$1,241.35 estimated

$1,075.09 + $161.26 (15%) + $5.00 fee per fill = $1,241.35

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TERIPARATIDE 560 MCG/2.24 ML PEN is how the CMS NADAC file names this product. The FDA NDC Directory lists it as teriparatide.

FDA gives its dosage form as “injection, solution” and “injection” and its route as subcutaneous.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Amphastar Pharmaceuticals, Inc. and Alvogen, Inc.

FDA’s Established Pharmacologic Class for it is Parathyroid Hormone Analog.

The NADAC file of 2026-10-14 prices it under 7 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1,075.09 for 2.24 mL (2.24 × $479.95105 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 6 labelers

LabelerNDCsPharmacies pay per unit
Prasco Laboratories2$479.95105 per ML filed
Alvogen, Inc.1$479.95105 per ML filed
Amphastar Pharmaceuticals, Inc.1$479.95105 per ML filed
Apotex Corp.1$479.95105 per ML filed
BluePoint Laboratories1$479.95105 per ML filed
Teva Pharmaceuticals USA, Inc.1$479.95105 per ML filed
All 7 NDCs, with labeler and price
  • 00093-1106-16 · Teva Pharmaceuticals USA, Inc. · $479.95105 per ML · eff. 2026-09-23 filed
  • 00548-2311-00 · Amphastar Pharmaceuticals, Inc. · $479.95105 per ML · eff. 2026-09-23 filed
  • 47781-0652-89 · Alvogen, Inc. · $479.95105 per ML · eff. 2026-09-23 filed
  • 60505-6188-00 · Apotex Corp. · $479.95105 per ML · eff. 2026-09-23 filed
  • 66993-0495-28 · Prasco Laboratories · $479.95105 per ML · eff. 2026-09-23 filed
  • 66993-0989-28 · Prasco Laboratories · $479.95105 per ML · eff. 2026-09-23 filed
  • 68001-0693-76 · BluePoint Laboratories · $479.95105 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name teriparatide with TERIPARATIDE 560 MCG/2.24 ML PEN.

ProductPharmacies pay per unitMedicare per unit
BONSITY 560 MCG/2.24 ML PEN
generic · injection, solution
$479.95105 per ML filed
eff. 2026-09-23
$962.4375 per ML filed
Part D 2024 average
FORTEO 560 MCG/2.24 ML PEN INJ
brand · injection, solution
$1,841.27488 per ML filed
eff. 2026-09-23
We don’t know yet
TERIPARATIDE 560 MCG/2.24 ML PEN this page
generic · injection, solution / injection
$479.95105 per ML filed
eff. 2026-09-23
$962.4375 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $2,155.86 for 2.24 mL, at an average of $962.4375 per ML in 2024 (2024-01-01 to 2024-12-31) for “Teriparatide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 81,093 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for TERIPARATIDE 560 MCG/2.24 ML PEN labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Teriparatide / Teriparatide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
Why does this page start at 2.24 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 2.24 mL in one package for all 7 NDCs of this product (“1 SYRINGE in 1 CARTON (0093-1106-16) / 2.24 mL in 1 SYRINGE”), so the card starts at one package: 2.24 ML. Change it to match your prescription.